Mammalian gene expression is tightly regulated by an array of posttranscriptional control programs, including mRNA translation and stability. The mRNA 3′ untranslated region (3′ UTR) plays a critical part in post-transcriptional control by cis-acting elements, such as micro RNA (miRNA)-target sites and AREs 1,2 . These RNA elements are targeted by miRNAs and ARE-binding proteins (ARE-BPs). TTP is an ARE-BP, which represents the prototypical member of the 12-O-tetradecanoylphorbol-13-acetate (TPA)-inducible sequence-11 (TIS11) family of RNA-binding proteins that include the TTP-related proteins butyrate response factors . TTP is an important regulator of the inflammatory response and a bona fide tumor suppressor in lymphomas [6] [7] [8] [9] . TTP, along with BRF-1 and BRF-2, binds AREs in the 3′ UTRs of target mRNAs through their tandem zinc-finger domains 10 to promote mRNA deadenylation and subsequent decay by recruiting the CCR4-NOT complex 11 . The N-terminal and C-terminal domains of TTP effect deadenylation through the CCR4-NOT complex 11, 12 . However, controversy exists with respect to how TTP interacts with the deadenylase machinery. One report concluded that components of the CCR4-NOT complex interact only with the TTP N-terminal domain 11 , whereas another only documented interactions with the TTP C-terminal domain 12 . Thus, it is currently unclear how TTP physically interacts with the CCR4-NOT complex to bring about deadenylation.
a r t i c l e s binding assays (Fig. 1c) . In contrast, it bound the TTP C-terminal domain very efficiently (~50% of input) (Fig. 1c) . Sequence alignment of the TTP C-terminal domain (CTD) and its related proteins BRF-1 and BRF-2 revealed two conserved patches of amino acids in the TTP-CTD: residues 179-192 and 314-326 ( Supplementary  Fig. 2 ). GST-CNOT1 800-1015 bound MBP-TTP lacking residues 179-192 (TTP-MUT1; Fig. 1a,c) . However, MBP-TTP lacking the terminal 13 amino acids (aa) (TTP-MUT2) failed to bind GST-CNOT1 (Fig. 1a,c) . Notably, the TTP C-terminal amino acid sequence is highly conserved in Tis11 homologs, including in Xenopus tropicalis, Drosophila melanogaster and Caenorhabditis elegans (Fig. 1d) . Taken together, these results demonstrate that CNOT1 interacts with an evolutionarily conserved amino acid motif at the C terminus of TTP.
Structural determination of the TTP-CNOT1 interaction
To gain structural insight into the CNOT1-TTP interaction, we solved the crystal structure of a TTP-interacting fragment of CNOT1 (residues 800-999) in complex with a peptide covering residues Ala312 to Glu326 of human TTP (hTTP; Fig. 1d ) at 1.5-Å resolution ( Fig. 2a and Table 1 ). The N-terminal 20 residues (800-819) of the CNOT1 fragment are disordered, whereas TTP could be modeled from residues Arg314 to Ser325. CNOT1 820-999 consists of eight α-helices stacked as a series of helix-turn-helix motifs in an arrangement similar to that of the HEAT repeats of the middle domain of initiation factor 4G (MIF4G) 15 ( Supplementary Fig. 3a) . The MIF4G domain is generally used as a protein-protein interaction domain and is found in numerous scaffolding proteins involved in the regulation of translation and RNA metabolism 16 . The main difference between the CNOT1 domain and the MIF4G domain resides at the N-terminal region, where the MIF4G domain forms the first HEAT repeat. In CNOT1, this region forms a long loop held in place by Trp828, which folds over α3 and contributes to a highly acidic surface adjacent to the TTP-binding site (not shown in figure) .
The TTP-binding site is located close to the N terminus of CNOT1 and is formed by a highly conserved hydrophobic groove between helices α1 and α3 that is flanked by negatively charged patches of amino acids (Fig. 2b) . The central portion of the TTP peptide forms a short, two-turn amphipathic α-helix resulting in the insertion of Leu316, Ile318, Phe319 and Ile322 into the hydrophobic groove of CNOT1 (Fig. 3a) . The bottom of the groove is lined with aromatic residues Phe847, Tyr851 and Tyr900 (Fig. 3b) . A network of electrostatic interactions between several polar residues located at the termini of the TTP peptide and the surrounding negatively charged residues in CNOT1 is also formed. The most prominent of these interactions is a salt bridge between Glu893 of CNOT1 and Arg315 of a NTD   1  TTP   TTP-FL   TTP-NTD   TTP-CTD  TTP-MUT1   TTP-MUT2   100 174  326 
GST pulldown Fig. 1c and Supplementary Fig. 1 (Fig. 3b) . Hydrogen-bonding between Glu893 and Tyr900 of CNOT1 with residues Arg315 and Ser323 of TTP, respectively, generates a stable closed-loop conformation in the TTP peptide (Fig. 3b) . Additional contacts stabilizing the complex are provided by hydrogen bonds on the solvent-exposed side of the TTP helix between residues Pro317 and Arg321 of TTP with Asn844 and Gln848 of CNOT1, respectively (Fig. 3b) . The sum of these interactions confers an affinity (K d ) of ~2 µM between the TTP peptide and CNOT1 800-999 as measured by isothermal titration calorimetry (ITC) experiments (Supplementary Fig. 3 ).
We generated mutants of TTP to biochemically validate the structure. Alanine substitutions of Arg315, which makes a salt bridge with Glu893 of CNOT1, and Phe319, which is at the center of the hydrophobic interaction site and forms van der Waals contacts with the CNOT1 surface ( Supplementary Fig. 4a ), in the TTP-CTD abolished its interaction with CNOT1 800-1015 in vitro (Fig. 3c) . In addition, mutating Phe319 to alanine in the TTP peptide disrupted its binding to CNOT1 800-999 (K d = ~7 mM; Supplementary Fig. 3c ). Mutation of Asn320, which does not make contact with CNOT1, to alanine failed to disrupt the TTP-CNOT1 interaction (Fig. 3c) . Taken together, these data demonstrate that the TTP-CNOT1 interaction requires several invariant residues in the C terminus of TTP, a sequence we now refer to as a TTP-CCR4-NOT interaction motif (TTP-CIM).
TTP-CNOT1 contact promotes mRNA deadenylation in vitro TTP requires its CTD to effect maximal deadenylation of target mRNAs 11, 12 . To examine the functional significance of the interaction between CNOT1 and TTP, we established an in vitro assay for TTP-mediated deadenylation. Using the λN-BoxB system 17 , we artificially tethered recombinant TTP proteins to an RNA reporter containing five BoxB stem loops and a 98-nucleotide poly(A) tail (5-BoxB-pA), which was added to a cell-free extract derived from mouse Krebs-2 ascites (termed Krebs extract; Fig. 4a ). This strategy has been used successfully to biochemically dissect the mechanics of miRNA-mediated deadenylation by the CCR4-NOT complex 18 . Recombinant wild-type GST-TTP was unable to mediate deadenylation, whereas wild-type GST-λNHA-TTP engendered complete deadenylation of 5-BoxB-pA RNA in the Krebs extract within 2 h (Fig. 4b) . In contrast, a TTP mutant that could not bind CNOT1 (TTP-F319A) displayed severely impaired deadenylation, with deadenylation barely detectable by 2 h (Fig. 4b) . Similar results were obtained when using a polyadenylated reporter containing two TTP-binding sites derived from the tumor necrosis factor 3′ UTR (TNF-ARE-pA), a bona fide TTP mRNA target (Fig. 4c) . Wild-type GST-TTP engendered complete deadenylation of TNF-ARE-pA by 2 h, whereas GST-TTP-F319A displayed partial and incomplete deadenylation (Fig. 4d) . Taken together, these results demonstrate that TTP-mediated deadenylation in vitro requires the TTP-CTD-CNOT1 interaction, irrespective of whether TTP is directly binding or being artificially tethered to a target RNA. 
TTP-CNOT1 contact promotes mRNA decay in vivo
We also examined the significance of the TTP-CNOT1 interaction on the stability of a TTP-targeted reporter mRNA in vivo. We used a plasmid containing the mouse MARCKS-like protein (MLP) promoter and coding region that is fused to the TTP-targeted TNFα 3′ UTR (MLP-TNF3′), which has previously served as a reporter to assay TTP function in cell cultures 19 . HEK-293 cells were co-transfected with the MLP-TNF3′ reporter plasmid along with a plasmid coding for either (i) GFP, (ii) wild-type TTP or (iii) various TTP mutants (Fig. 4e,f) . We observed markedly less MLP-TNF3′ RNA in wild-type TTP-expressing cells as compared to GFP-expressing cells, indicative of an increase in reporter mRNA degradation. Similar effects on MLP-TNF3′ RNA stability were observed in cells expressing a TTP mutant that contains the TTP-CIM but lacks four C-terminal amino acids (1-322). In contrast, MLP-TNF3′ RNA was strongly stabilized in cells expressing a TTP mutant in which an additional 9 aa have been deleted, thereby removing the TTP-CIM (1-313). Thus, these results suggest that TTP requires its C-terminal CNOT1-interacting motif to bring about efficient decay of a target mRNA in vivo.
DISCUSSION
We have identified a CIM at the C terminus of human TTP. The TTP-CIM directly binds the CNOT1 subunit of the CCR4-NOT complex. Notably, this represents the first structure, to our knowledge, of the interface between an ARE-BP and the CCR4-NOT complex.
Furthermore, our data demonstrate that optimal TTP-mediated deadenylation requires the TTP-CIM to be bound to CNOT1, as disrupting this interaction impairs, but does not completely abolish, deadenylation in vitro (Fig. 4a,b) and mRNA decay in vivo (Fig. 4c) . These data fit well with previous studies demonstrating that the TTP N-terminal domain facilitated deadenylation of target mRNAs in a manner dependent on the CCR4-NOT complex. How the deadenylase machinery interacts with the TTP N-terminal domain remains to be determined. Notably, the TTP-binding domain of CNOT1 is N-terminally adjacent to the CNOT1 domain that binds the CAF1 deadenylase 20, 21 . It is therefore plausible that TTP binding next to CAF1 on CNOT1 may help position the CAF1 deadenylase so that it has unimpeded access to the mRNA poly(A) tail (Fig. 4g) . TTP residues that interact with CNOT1 are phylogenetically conserved in Tis11 proteins, including the D. melanogaster Tis11 homolog and the C. elegans protein CCCH-1 (Fig. 1d) . Moreover, CNOT1 residues that form a groove, which contains amino acids that interact with the TTP-CIM (Phe847, Tyr851, Glu893 and Tyr900), are highly conserved across these species as well ( Supplementary  Fig. 4b) . A recent study reported the crystal structure of the yeast Not1 N-terminal region (residues 154-753) 20 . It consists of 13 HEAT repeats, of which repeats 10-13 (residues 571-746) correspond to the four HEAT repeats found in human CNOT1 800-999 . Although yeast Not1 and human CNOT1 proteins share only 35% sequence identity in this region, the structures are very similar, with a Cα r.m.s. deviation of 1.19 Å (Supplementary Figs. 4c,d) . Notably, yeast Not1 HEAT repeats 10-13 form a separate unit within the protein in that they are arranged in a parallel fashion while there is a rotation by 90° with respect to repeats 1-9 (ref. 20) . This suggests that HEAT repeats 10-13 form a separate domain. Our results confirm this notion because we show that this domain is stable and can carry out its function of TTP recruitment in the absence of the more N-terminal HEAT repeats. The residues in human CNOT1 that form the TTP-docking site are also conserved in yeast Not1, which suggests that they may also act as a protein-binding site. However, the yeast Tis11 homolog CTH1 (cysteine three histidine 1) does not contain a sequence that shares any detectable homology to the hTTP-CIM. Nevertheless, it is conceivable npg a r t i c l e s that ancient NOT1 proteins maintained this protein-interaction groove, which was exploited during the course of eukaryotic evolution by proteins such as TTP. CNOT1 binds the miRNA-associated GW182 protein through two conserved CIMs and additional tryptophan-containing sequences 18, 22 . However, the TTP-CIM does not share homology with the GW182 CIMs, which suggests that TTP and GW182 bind different regions of CNOT1. Mouse TTP activity is controlled by phosphorylation on a number of residues, including Ser52 and Ser178 (Ser60 and Ser186 in human TTP, respectively) by the p38 MAPK-activated protein kinase 2 (MK2) (ref. 23 ). Ser52 and Ser178, when phosphorylated, act as substrates for 14-3-3 adaptor proteins that bind and stabilize TTP 23, 24 . Phosphorylation of TTP by MK2 also impairs TTP recruitment of the CCR4-NOT complex and TTP-mediated deadenylation 25, 26 . On the basis of these data, it has been postulated that 14-3-3 binding to TTP impairs deadenylase recruitment 26 . However, our data demonstrate that 14-3-3-binding sites (Ser52 and Ser178) do not overlap with the C-terminal TTP-CIM. Notwithstanding these data, MK2-induced TTP phosphorylation partially inhibits association with CCR4-NOT even when these serines are mutated in tandem to alanines, thereby abolishing 14-3-3 binding 26 . It has therefore been suggested that additional phosphorylation sites act to inhibit deadenylase recruitment to TTP 26 . Notably, MK2 has also been reported to phosphorylate TTP and BRF-1 on a highly conserved serine residue residing within the TTP-CIM (Ser323 in hTTP; Fig. 1d ) 23 . Our structural data indicate that Ser323 forms multiple contacts at the TTP-CNOT1 interface, both within the TTP peptide and with CNOT1 (Fig. 3b) . Thus, the addition of a phosphate group to Ser323 would probably perturb TTP-CNOT1 binding. Indeed, a TTP-CIM peptide containing a phosphoSer323 binds with a markedly lower affinity to CNOT1 800-999 (K d = ~625 µM; Supplementary Fig. 3d ) as compared to wild type. Taken together, these data suggest that the ability of the TTP-CIM to bind CNOT1 is regulated through the p38 signaling pathway. This model may help explain how MK2 phosphorylation regulates TTP recruitment of the CCR4-NOT complex. It is possible that 14-3-3 proteins and the CCR4-NOT complex compete for TTP binding. Phosphorylation of Ser323 may therefore aid the TTP transition from being bound to the CCR4-NOT complex to interacting with 14-3-3 proteins. Whether this post-translational modification has a role in regulating TTP-mediated silencing, however, remains to be determined.
METHODS
Methods and any associated references are available in the online version of the paper. 
